Skip to main content

Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine.

Journal articles  - Journal Article
Stokdyk, K; Sahoo, A; Gangadhara, S; Williams, LD; Styles, TM; Hellman, CA; Zhang, L; Odeh, AJ; Flaherty, S; Shen, X; Rahman, MA; Norton, EB ...
Published in: Front Immunol
2025

The development of an effective HIV-1 vaccine is of paramount importance to global health. Here, we compared the influence of two adjuvants, Escherichia coli double-mutant heat-labile toxin (dmLT) and alum, on the protective immunity induced by a cyclically permuted trimeric HIV-1 envelope gp120 protein (CycP-gp120) boost. Two groups of rhesus macaques received two modified vaccinia Ankara (MVA)/SHIV C.1086 primes followed by a CycP-gp120 protein boost adjuvanted with either dmLT (n = 9) or alum (n = 10). A group of unvaccinated macaques (n = 8) served as controls. All animals were intrarectally challenged with heterologous SHIV.CH505.375H.dCT weekly for 7 weeks. Following the challenge, dmLT-adjuvanted animals showed significant protection with a vaccine efficacy of 60.8% per exposure (p = 0.0246). Alum-adjuvanted animals did not show significant protection (p = 0.1575). Both adjuvants induced comparable envelope-specific binding antibody in serum and rectal secretions with broad V1V2 scaffold-binding specificity. IL-6 plasma concentration correlated positively with V1V2 scaffold-binding and increased after vaccination with both adjuvants. With respect to CD4 T cells, dmLT induced higher frequencies of proliferating central memory (TCM) and ICOS+ cells in blood compared to alum. However, these proliferating CD4 TCM cells showed a decrease in the proportion of gut-homing receptor α4β7-expressing cells in the dmLT group compared to the alum group at week 2 post-protein boost. The V1V2 scaffold-specific IgG, proliferating TCM and ICOS+ CD4 T-cell frequencies, and plasma IL-6 concentration associated positively with protection. These data demonstrate that the vaccine adjuvants dmLT and alum differentially modulate protective helper T-cell responses induced by the CycP-gp120 protein, highlighting the importance of an appropriate adjuvant for eliciting a protective immune response against HIV-1.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Front Immunol

DOI

EISSN

1664-3224

Publication Date

2025

Volume

16

Start / End Page

1706958

Location

Switzerland

Related Subject Headings

  • Macaca mulatta
  • Immunogenicity, Vaccine
  • Humans
  • HIV-1
  • HIV Infections
  • HIV Envelope Protein gp120
  • HIV Antibodies
  • Escherichia coli Proteins
  • Enterotoxins
  • CD4-Positive T-Lymphocytes
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stokdyk, K., Sahoo, A., Gangadhara, S., Williams, L. D., Styles, T. M., Hellman, C. A., … Amara, R. R. (2025). Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine. Front Immunol, 16, 1706958. https://doi.org/10.3389/fimmu.2025.1706958
Stokdyk, Kasey, Anusmita Sahoo, Sailaja Gangadhara, LaTonya D. Williams, Tiffany M. Styles, Caleb A. Hellman, Lu Zhang, et al. “Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine.Front Immunol 16 (2025): 1706958. https://doi.org/10.3389/fimmu.2025.1706958.
Stokdyk K, Sahoo A, Gangadhara S, Williams LD, Styles TM, Hellman CA, et al. Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine. Front Immunol. 2025;16:1706958.
Stokdyk, Kasey, et al. “Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine.Front Immunol, vol. 16, 2025, p. 1706958. Pubmed, doi:10.3389/fimmu.2025.1706958.
Stokdyk K, Sahoo A, Gangadhara S, Williams LD, Styles TM, Hellman CA, Zhang L, Odeh AJ, Flaherty S, Shen X, Rahman MA, Norton EB, Franchini G, Montefiori D, Kozlowski PA, Tomaras GD, Amara RR. Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine. Front Immunol. 2025;16:1706958.

Published In

Front Immunol

DOI

EISSN

1664-3224

Publication Date

2025

Volume

16

Start / End Page

1706958

Location

Switzerland

Related Subject Headings

  • Macaca mulatta
  • Immunogenicity, Vaccine
  • Humans
  • HIV-1
  • HIV Infections
  • HIV Envelope Protein gp120
  • HIV Antibodies
  • Escherichia coli Proteins
  • Enterotoxins
  • CD4-Positive T-Lymphocytes